<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Cancer News</title>
<link>http://phys.org/health-news/cancer/</link>
<language>en-us</language> 
<description>Phys.Org provides the latest news on cancer, health, medicines, cancer treatments, cancer research, cancer studies and types of cancer.</description>

 <item>
     <title>Mobile phones 'don't cause cancer': yet another study</title>
   	 <description>Scientific evidence goes increasingly against the theory that mobile phones cause cancer, a new study has concluded.</description>
     <link>http://phys.org/news228821254.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Sat, 02 Jul 2011 10:27:44 EST</pubDate>
	 <guid isPermaLink="false">news228821254</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/thenumberofb.jpg" width="90" height="90" />
</item>
<item>
     <title>Lung cancer scans: False alarms amid lives saved</title>
   	 <description>(AP) -- Full results of a big study that showed some smokers' lives could be saved by screening with lung scans now reveal more clearly what the risks are: There's a good chance of a false alarm.</description>
     <link>http://phys.org/news228587934.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 29 Jun 2011 17:39:04 EST</pubDate>
	 <guid isPermaLink="false">news228587934</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/lungcancersc.jpg" width="90" height="90" />
</item>
<item>
     <title>Study: Docs overtesting for cervical cancer virus</title>
   	 <description>(AP) --  Too many doctors are testing the wrong women, or using the wrong test, for a virus that causes cervical cancer.</description>
     <link>http://phys.org/news227812217.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 20 Jun 2011 18:10:34 EST</pubDate>
	 <guid isPermaLink="false">news227812217</guid>
	 
</item>
<item>
     <title>Cancer death rate gap widens based on education</title>
   	 <description>(AP) --  The gap in cancer death rates between college graduates and those who only went to high school is widening, the American Cancer Society reported Friday.</description>
     <link>http://phys.org/news227502011.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Fri, 17 Jun 2011 04:00:34 EST</pubDate>
	 <guid isPermaLink="false">news227502011</guid>
	 
</item>
<item>
     <title>New rules to cut confusion on sunscreen claims</title>
   	 <description>(AP) -- Help is on the way to consumers confused by the jumble of sun protection numbers and other claims on sunscreens.</description>
     <link>http://phys.org/news227265485.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 14 Jun 2011 10:18:14 EST</pubDate>
	 <guid isPermaLink="false">news227265485</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/newrulestocu.jpg" width="90" height="90" />
</item>
<item>
     <title>Bristol-Myers pitches its cancer medicine pipeline</title>
   	 <description>(AP) --  Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.</description>
     <link>http://phys.org/news226595808.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 16:17:03 EST</pubDate>
	 <guid isPermaLink="false">news226595808</guid>
	 
</item>
<item>
     <title>Bayer flags strong results of prostate cancer drug</title>
   	 <description> German chemical and pharmaceutical group Bayer said Monday that its Alpharadin treatment for prostate cancer has shown positive results in advanced trials.</description>
     <link>http://phys.org/news226565285.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 07:48:24 EST</pubDate>
	 <guid isPermaLink="false">news226565285</guid>
	 
</item>
<item>
     <title>New chemo regimen helps children with neuroblastoma</title>
   	 <description> A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.</description>
     <link>http://phys.org/news226550549.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 03:42:47 EST</pubDate>
	 <guid isPermaLink="false">news226550549</guid>
	 
</item>
<item>
     <title>Studies find new drugs boost skin cancer survival</title>
   	 <description>(AP) --  They're not cures, but two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors reported Sunday.</description>
     <link>http://phys.org/news226549097.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 03:18:41 EST</pubDate>
	 <guid isPermaLink="false">news226549097</guid>
	 
</item>
<item>
     <title>Estrogen blocker cuts breast cancer risk 65%: study</title>
   	 <description> An anti-estrogen drug has shown a &quot;promising&quot; 65-percent reduction of breast cancer risk among post-menopausal women, according to the findings of a study released Saturday.</description>
     <link>http://phys.org/news226414782.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Sat, 04 Jun 2011 14:00:05 EST</pubDate>
	 <guid isPermaLink="false">news226414782</guid>
	 
</item>
<item>
     <title>Hormone-blocking drug reduces breast cancer risk</title>
   	 <description>(AP) --  Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found.</description>
     <link>http://phys.org/news226412912.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Sat, 04 Jun 2011 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news226412912</guid>
	 
</item>
<item>
     <title>HPV test beats Pap for cervical cancer screening</title>
   	 <description>Two big studies suggest possible new ways to screen healthy people for cervical or prostate cancers, but a third disappointed those hoping for a way to detect early signs of deadly ovarian tumors.</description>
     <link>http://phys.org/news224961785.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 18 May 2011 18:23:31 EST</pubDate>
	 <guid isPermaLink="false">news224961785</guid>
	 
</item>
<item>
     <title>Study urges three-year gap in cervical cancer test</title>
   	 <description> Healthy women over 30 who test negative for human papillomaviruses (HPV) may be able to safely extend the period between gynecological exams from every year to three years, said a US study Wednesday.</description>
     <link>http://phys.org/news224961648.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 18 May 2011 18:21:01 EST</pubDate>
	 <guid isPermaLink="false">news224961648</guid>
	 
</item>
<item>
     <title>Many with low thyroid missed because labs may be wrong</title>
   	 <description>     Millions of Americans - mostly women - could find the key to more energy, easier weight control, sharper thinking, less depression, less infertility, lower blood pressure and lower incidence of heart disease. It all depends on who wins a 10-year-old medical debate.</description>
     <link>http://phys.org/news224496162.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Fri, 13 May 2011 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news224496162</guid>
	 
</item>
<item>
     <title>Study: Many elderly get colon screening too often</title>
   	 <description>(AP) --  Many older Americans get repeat colon cancer tests they don't need and Medicare is paying for it, suggests a study that spotlights unnecessary risks to the elderly and a waste of money.</description>
     <link>http://phys.org/news224180002.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 09 May 2011 20:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224180002</guid>
	 
</item>
<item>
     <title>Study: Prostate cancer surgery helps younger men</title>
   	 <description>Men under 65 with early prostate cancer had better survival odds if they had surgery right away instead of waiting for treatment only if their cancer got worse, a study in Sweden found.</description>
     <link>http://phys.org/news223749145.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 04 May 2011 17:32:43 EST</pubDate>
	 <guid isPermaLink="false">news223749145</guid>
	 
</item>
<item>
     <title>RxPONDER trial will evaluate whether gene expression test can drive chemotherapy choice</title>
   	 <description>Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.</description>
     <link>http://phys.org/news223030244.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 26 Apr 2011 09:50:54 EST</pubDate>
	 <guid isPermaLink="false">news223030244</guid>
	 
</item>
<item>
     <title>Targeted agent selumetinib shows promise in biliary cancer</title>
   	 <description>The experimental agent selumetinib has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at The Ohio State University.</description>
     <link>http://phys.org/news222967807.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 25 Apr 2011 16:38:26 EST</pubDate>
	 <guid isPermaLink="false">news222967807</guid>
	 
</item>
<item>
     <title>Research brings new hope of renal recovery for cancer patients</title>
   	 <description>(PhysOrg.com) -- A new study conducted by researchers at the University of Birmingham has identified a 21 day treatment threshold to facilitate renal recovery and significantly improve survival rates of myeloma or Kahler's disease; a cancer of the bone marrow.</description>
     <link>http://phys.org/news222671594.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Fri, 22 Apr 2011 06:13:31 EST</pubDate>
	 <guid isPermaLink="false">news222671594</guid>
	 
</item>
<item>
     <title>A new ending to an old 'tail'</title>
   	 <description>In stark contrast to normal cells, which only divide a finite number of times before they enter into a permanent state of growth arrest or simply die, cancer cells never cease to proliferate. Now, scientists at the Salk Institute for Biological Studies have uncovered an important clue to one of the mechanisms underlying cancer cell immortality.</description>
     <link>http://phys.org/news222609023.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Thu, 21 Apr 2011 12:50:40 EST</pubDate>
	 <guid isPermaLink="false">news222609023</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/anewendingto.jpg" width="90" height="90" />
</item>
<item>
     <title>Presenting cancer treatment options in small doses yields smarter choices</title>
   	 <description>Women who choose among different breast cancer treatment options make smarter choices when getting the information and making decisions in small doses rather than all at once, as is customary, a University of Michigan study found.</description>
     <link>http://phys.org/news222538894.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 20 Apr 2011 17:21:43 EST</pubDate>
	 <guid isPermaLink="false">news222538894</guid>
	 
</item>
<item>
     <title>US approves Swiss firm's cervical cancer test</title>
   	 <description> Swiss pharmaceutical giant Roche has been given the green light by US authorities to market its test for screening cervical cancer, the company announced on Wednesday.</description>
     <link>http://phys.org/news222522001.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Wed, 20 Apr 2011 12:40:10 EST</pubDate>
	 <guid isPermaLink="false">news222522001</guid>
	 
</item>
<item>
     <title>Decoding cancer patients' genomes is powerful diagnostic tool</title>
   	 <description>Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.</description>
     <link>http://phys.org/news222451688.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 19 Apr 2011 17:08:22 EST</pubDate>
	 <guid isPermaLink="false">news222451688</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/decodingcanc.jpg" width="90" height="90" />
</item>
<item>
     <title>Taking aim at tumors: Novel way of studying cancer may inspire new treatments</title>
   	 <description>Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual's tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. At the forefront of this work are Binghamton University researchers, Susan Bane, and Susannah Gal, who are deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.</description>
     <link>http://phys.org/news222432578.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 19 Apr 2011 12:20:01 EST</pubDate>
	 <guid isPermaLink="false">news222432578</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/takingaimatt.jpg" width="90" height="90" />
</item>
<item>
     <title>Protein KO stops tumour growth</title>
   	 <description>(PhysOrg.com) -- Research published last week in the journal PNAS may have identified a promising new target for developing drugs against one of the most common types of lung cancer.</description>
     <link>http://phys.org/news222425004.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 19 Apr 2011 09:43:38 EST</pubDate>
	 <guid isPermaLink="false">news222425004</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/proteinkosto.jpg" width="90" height="90" />
</item>
<item>
     <title>Cell of origin for squamous cell carcinoma discovered</title>
   	 <description>Squamous cell cancers, which can occur in multiple organs in the body, can originate from hair follicle stem cells, a finding that could result in new strategies to treat and potentially prevent the disease, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.</description>
     <link>http://phys.org/news222424620.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 19 Apr 2011 09:37:23 EST</pubDate>
	 <guid isPermaLink="false">news222424620</guid>
	 
</item>
<item>
     <title>Study shows how inflammation can lead to cancer</title>
   	 <description>A new study shows how inflammation can help cause cancer. Chronic inflammation due to infection or to conditions such as chronic inflammatory bowel disease is associated with up to 25 percent of all cancers.</description>
     <link>http://phys.org/news222424253.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Tue, 19 Apr 2011 09:32:33 EST</pubDate>
	 <guid isPermaLink="false">news222424253</guid>
	 
</item>
<item>
     <title>Breakthroughs help brain surgeons remove nearly all of a tumor, raise survival rates</title>
   	 <description>Donna Vinson suddenly felt she &quot;couldn't think well.&quot; She was far off from choosing the right words, even pointing to a garbage can once as she asked a family member to pass the potatoes.</description>
     <link>http://phys.org/news222363693.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 18 Apr 2011 17:10:01 EST</pubDate>
	 <guid isPermaLink="false">news222363693</guid>
	 
</item>
<item>
     <title>New scientific model tracks form of ovarian cancer to origins in fallopian tube</title>
   	 <description>High-grade serous ovarian cancer (HGSOC), the fifth-deadliest cancer among American women, is thought by many scientists to often be a fallopian tube malignancy masquerading as an ovarian one. While most of the evidence linking HGSOC to the fallopian tubes has so far been only circumstantial, a new Dana-Farber Cancer Institute study suggests there is a direct connection, a finding that could aid in the development of better treatments for the cancer.</description>
     <link>http://phys.org/news222361125.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 18 Apr 2011 15:58:56 EST</pubDate>
	 <guid isPermaLink="false">news222361125</guid>
	 
</item>
<item>
     <title>Breast cancer prognosis goes high tech</title>
   	 <description>Cancer researchers at the University of Calgary are investigating a new tool to use for the prognosis of breast cancer in patients. This new digital tool will help give patients a more accurate assessment of how abnormal and aggressive their cancer is and help doctors recommend the best treatment options.</description>
     <link>http://phys.org/news222338057.html</link>
	 <category>Medicine &amp; Health - Cancer</category>
	 <pubDate>Mon, 18 Apr 2011 09:34:29 EST</pubDate>
	 <guid isPermaLink="false">news222338057</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/breastcancer.jpg" width="90" height="90" />
</item>


</channel>
</rss>
